MeSH tree: C20.543.480.343
Atopic dermatitis (AD), the most common form of eczema, impacts patients' life trajectories beyond the physical scars. A novel study shows that adults with AD, particularly those with childhood onset, report significantly ...
May 28, 2026
0
8
A history of atopic dermatitis (AD) is associated with an increased risk for retinal detachment (RD), according to a study published in Ophthalmology Retina.
May 25, 2026
0
6
Most people living with severe asthma are also battling other health conditions that go under the radar, a major new study has found. Researchers analyzing data from thousands of patients discovered that the additional illnesses—which ...
May 19, 2026
0
2
Friendly skin bacteria could hold the key to stopping eczema in its tracks, according to a breakthrough by a team of UK and Japanese scientists. Their new study reveals harmless microbes living on our skin release powerful ...
May 14, 2026
0
16
Creativity and curiosity have always been central to the work of Joshua Moreau, Ph.D., an immunologist whose work at Oregon Health & Science University sits at the intersection of harnessing the immune system; delving into ...
May 8, 2026
0
3
Adults with more severe atopic dermatitis (AD) are at risk for sleep and memory disturbances, according to a study published online April 21 in Dermatitis.
Apr 27, 2026
0
7
Machine learning models can predict the risk for developing moderate-to-severe persistent asthma and allergic rhinitis in children diagnosed with early-life atopic dermatitis, according to a study published online April 17 ...
Apr 25, 2026
0
4
Increasing maternal prepregnancy body mass index (ppBMI) and increasing birth length are associated with offspring atopic dermatitis by age 3 years, according to a study published online March 23 in the Journal of Allergy ...
Apr 10, 2026
0
3
There's very little parents can do to prevent their kids from developing eczema, according to new guidelines from the American Academy of Dermatology (AAD). Research hasn't shown that common tactics like special diets, skipping ...
Apr 9, 2026
0
4
Amlitelimab, a fully human non-T cell depleting monoclonal antibody that selectively targets OX40-ligand (OX40L), is safe and effective, with potentially progressive efficacy over time, for patients with moderate-to-severe ...
Apr 8, 2026
0
7
